Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Grace Breeding Ltd. (GRAC.TA)
Ramat Gan, TA, IL
Grace Breeding Ltd, an agro-tech company, engages in the research and development in the area of biological substitutes for synthetic materials used in the fertilizer and growth promoter industries in Israel and internationally. The company also sells seeds. Its product portfolio includes Maoz, a biofertilizer that aids with photosynthesis; ProMagen, a combination of plant materials with anti-inflammatory properties for biotic stress tolerance; and ClimAid for abiotic stress tolerance. Grace Breeding Ltd was incorporated in 2015 and is based in Ramat Gan, Israel.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +1.37% | -1.62% | -3.19% | -19.81% | -5.13% | -12.82% | +130.04% | -35.46% | -35.46% | -35.46% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Agricultural Inputs: +9.5%-100.0% Q4'25: -100.0% (vs Q4'23)
-
EPS growth Agricultural Inputs: +23.0%+14.3% Q4'25: +75.9% (vs Q4'23)
-
FCF margin FCF growth · Agricultural Inputs: +27.6%—
-
EBIT margin Agricultural Inputs: +9.7%—
-
ROIC Agricultural Inputs: +7.4%— Q4'25: +640.1% (vs Q4'23)
-
Share dilution Agricultural Inputs: +0.0%+4.1% Q4'25: +14.8% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Inputs: 0.03×0.00× Q4'25: 0.00× (vs Q4'23)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-25 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Moti Mordechai | Vice President of Commercial | 188.0K | male |
| Ofer Amir | Investor Relations Consultant | 65.0K | male |
| Joseph Raveh | Chief Operating Officer & Director | 52.0K | male |
| Morris Zelkha | Chief Executive Officer & Chairman | 52.0K | male |
| Orly Shuster | Chief Financial Officer | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GRAC.TA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
